In Brief: FDA's Pulmonary-Allergy Drugs Advisory Committee
Executive Summary
FDA's Pulmonary-Allergy Drugs Advisory Committee: On March 27, will hold a joint meeting with the nonprescription drugs committee to consider the efficacy of antihistamines for treatment of the common cold. The meeting will begin at 8 a.m. at FDA's Parklawn Building, Conference Rooms D&E...